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ABSTRACT
Objective To evaluate the predictive value of alarm
symptomsforspecifiednon-cancerdiagnosesandcancer
diagnoses in primary care.
Design Cohort study using the general practice research
database.
Setting128generalpracticesintheUKcontributingdata,
1994-2000.
Participants 762325 patients aged 15 or older.
Main outcome measures Up to 15 pre-specified, non-
cancer diagnoses associated with four alarm symptoms
(haematuria,haemoptysis,dysphagia,rectalbleeding)at
90 days and three years after the first recorded alarm
symptom. For each outcome analyses were implemented
separately in a time to event framework. Data were
censored if patientsdied, left the practice, or reached the
end of the study period.
ResultsWeanalyseddataonfirstepisodesofhaematuria
(11108), haemoptysis (4812), dysphagia (5999), or
rectal bleeding (15289). Non-cancer diagnoses were
commoninpatientswhopresentedwithalarmsymptoms.
The proportion diagnosed with either cancer or non-
cancer diagnoses generally increased with age. In
patients presenting with haematuria, the proportions
diagnosed with either cancer or non-cancer diagnoses
within 90 days were 17.5% (95% confidence interval
16.4% to 18.6%) in women and 18.3% (17.4% to 19.3%)
in men. For the other symptoms the proportions were
25.7% (23.8% to 27.8%) and 24% (22.5% to 25.6%) for
haemoptysis, 17.2% (16% to 18.5%) and 22.6% (21% to
24.3%) for dysphagia, and 14.5% (13.7% to 15.3%) and
16.7% (15.8% to 17.5%) for rectal bleeding.
Conclusion Clinically relevant diagnoses are made in a
high proportion of patients presenting with alarm
symptoms. For every four to seven patients evaluated for
haematuria, haemoptysis, dysphagia, or rectal bleeding,
relevant diagnoseswill be identified in one patient within
90 days.
INTRODUCTION
MostmajorandminorillnessesintheUnitedKingdom
are managed by general practitioners and, in other
countries, by generalist primary care physicians.
1 The
number of new cases of serious illness seen each year
by an individual general practitioner, however, is
relatively small. For example, each of the 42000 gen-
eral practitioners in the UK will see about seven new
cancers, three to four strokes, and five to six myo-
cardial infarctions each year, assuming a notional list
sizeof1800-2000.
2Manyyearsago,however,Thomas
noted that up to 40% of patients presenting in primary
care and observed over a two week period recover
without specific treatment and often without a specific
diagnosis being made.
3
Operating in conditions of diagnostic uncertainty,
general practitioners have the often difficult task of
separating the minority of patients whose symptoms
could indicate serious disease and who require urgent
diagnosticattentionfromthemajoritywithlessserious,
self limiting illness,
4 in whom time can often be used
both as a “diagnostic and therapeutic tool.”
56To make
these difficult judgments general practitioners use var-
ious personal “heuristics”—commonsense rules often
involving the use of questions thought to have high
negative or positive predictive values to rule out ser-
ious disease and often without a firm evidence base to
supportthem.
7-9Thishasledtocontinuinguncertainty
abouttheoptimumuseandtimingofinvasiveorcostly
investigations (such as endoscopy and imaging) and
controversy about the content of clinical practice
guidelines. For example, our limited knowledge of
the epidemiology of common cancers has formed the
basisofreferralguidelines,includingthetwoweekrule
intheUK,whichprovidesrapidaccesstospecialistsfor
patientspresentinginprimarycarewithsymptomsthat
might indicate cancer. There is uncertainty, however,
aboutwhetherthisapproachhasresultedinmorerapid
identification of cancers at a more treatable stage.
10
Another example of the need for more diagnostic
research concerns the investigation of upper gastro-
intestinal symptoms and the relative roles of upper
gastrointestinal endoscopy, Helicobacter pylori testing,
and empirical acid suppression, which have been
debated for many years without a firm conclusion
being reached.
11-13
There is a need for more “diagnostic research” to
generatetheevidencebaseonwhichtorefinediagnos-
tic criteria in primary care and to develop decision
rules for the management of symptoms and symptom
complexes. In his recent publication on evidence
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14 found few
studies in primary care that provide accurate informa-
tion about the predictive value of common symptoms,
emphasising the need for more research of this kind.
Previously we used the general practice research
database to study the incidence of cancers in patients
presenting in primary care with four “alarm symp-
toms”—haematuria, dysphagia, haemoptysis, and rec-
tal bleeding.
15 We have now used the database to
examine the identification of non-cancer diagnoses in
patients presenting with alarm symptoms. The data-
baseistheworld’slargestprimarycaredatabase,hold-
ing clinical and healthcare information on around 13
million patient years. Several hundred representative
general practices in the UK contribute data, and the
structure, utility, and validity of the database and the
data extracted from it have been widely described and
validated.
1617Theriskofacancerdiagnosisinthethree
year period after presentation with alarm symptoms
was 8.0% for haematuria in men and 3.7% in women,
with corresponding figures of 8.0% and 4.5% for hae-
moptysis, 5.9% and 2.5% for dysphagia, and 2.7% and
2.1% for rectal bleeding. Additionally, individual
alarm symptoms had surprisingly high predictive
values in certain groups of patients—notably, those in
older age groups—although of course most patients
with these symptoms did not have cancer.
Itcan,however,bejustasimportanttomakeanearly
accurate diagnosis of a serious non-malignant condi-
tion so that treatment can be instituted promptly.
Clear guidance on the likely yield of early investiga-
tions (rather than using time as a diagnostic tool and
waiting for diagnoses to emerge) is urgently needed.
We report on the incidence of a range of pre-specified
non-cancer diagnoses and provide predictive values
for a range of diagnoses associated with alarm symp-
toms,definingthecharacteristicsofpatientspresenting
with alarm symptoms who turn out to have these diag-
noses at 90 days and three years after presentation.
METHODS
The methods have been described in our previous
report.
15Weselectedall128generalpracticesthatpro-
vided up to standard data from 1 January 1994 to 31
December2000andwhosedatawereexclusivelyRead
coded. We selected all 923605 patients who were per-
manently registered with these practices between 1
January and 31 December 1994 and were aged 100
or less in 1994. There were few patients aged over
100 and data quality and approaches to diagnosis
might differ in very old age. From these, we identified
patients whose first ever recorded occurrence of each
alarm symptom (macroscopic haematuria, haemopty-
sis, dysphagia, or rectal bleeding) was after 31 Decem-
ber1995orwhowerediagnosedwithneoplasmsofthe
urinary tract, respiratory tract, oesophagus, or colon
and rectum.
To include only those patients who were previously
freefromcancer,weexcludedallthosewithadiagnosis
of any other cancer than the ones of interest before the
date of the first recorded symptom, or before the date
ofdiagnosisoftheindexcanceriftherelatedsymptom
wasnotrecorded.Weexcluded patientsagedlessthan
15 at the time of the first symptom, patients with
incomplete dates for diagnosis of either symptom or
cancer,andpatientswhosefirstrecordeddateofsymp-
tom was later than the date of cancer diagnosis.
In this study we included only patients who had a
first ever alarm symptom, with a complete date,
recorded between 1 January 1995 and 31 December
2000, and whose data were up to standard at the date
of the symptom.
We constructed a list of pre-specified, potentially
important diagnoses (that is, conditions that generally
require treatment or are likely to be progressive, or
both) for each of the alarm symptoms by referring to
recently published standard textbooks describing dif-
ferentialdiagnosesinprimarycareandvalidatedthese
lists by circulating and discussing them with general
practitioner colleagues. For haematuria we included
urinary tract cancer, kidney stone, benign prostatic
hyperplasia,orchitis,urinarytractinfection,menstrual
disorders, glomerulonephritis, urethritis, bleeding dis-
orders,renaltuberculosis,polycystickidneys,infective
endocarditis,schistosomiasis,andcancersoftheuterus
andprostate.Forhaemoptysisweincludedrespiratory
tract cancer, acute upper respiratory infection, acute
lower respiratory infection, chronic obstructive pul-
monary disease, bronchiectasis, asthma, influenza,
pulmonary embolism, bleeding disorders, pulmonary
oedema/left ventricular failure, mitral stenosis, poly-
arteris nodosa, pulmonary tuberculosis, aspergillosis,
Goodpasture’s syndrome, and pulmonary atrioventri-
cular malformation. For dysphagia we included upper
gastrointestinal cancers, oesophagitis, oesophageal
stricture, hiatus hernia, gastritis, stomach disorders,
pepticulcer(includinggastricandduodenalulcer),glo-
bus hystericus, pharyngeal pouch, Chagas’ disease,
scleroderma, myasthenia gravis, achalasia, and gastric
cancer. Finally, for rectal bleeding we included color-
ectal and anal cancer, diverticulitis, anal fissure,
Crohn’s disease, ulcerative colitis, infectious gastro-
enteritis, haemorrhoids, peptic ulcer, bleeding disor-
ders, angiodysplasia, intussusception, and Meckel’s
diverticulum. Sets of Read codes were identified for
each condition.
Analyses were implemented in a time to event fra-
mework. Separate analyses were conducted for each
outcome. The start date was the date of the first con-
sultationfor the alarm symptom.Theend date wasthe
date of the first recorded outcome event. Data were
censored if patients left the practice or died. We esti-
mated the proportion in whom the outcome was
recorded before 90 days and three years from the fail-
ure function using the “sts list” command in Stata ver-
sion10.Thus,thepositivepredictivevalueofanalarm
symptom for cancer was estimated as the proportion
diagnosed with the outcome by 90 days or three
years after adjustment for deaths and censoring. We
collected data at 90 days and three years because the
former represents an upper limit of time in which a
practitioner might aim to make a diagnosis after
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might represent an upper limit of time during which
serious clinical diagnoses would become evident. We
carried out a sensitivity analysis in which we included
deaths before the outcome of interest in a competing
risksanalysis
18usingthe“stcompet”commandinStata
version10.Resultsshowednegligibledifferencesfrom
the initial analysis. An individual patient could have a
diagnosis of more than one of the outcome events.
Tests for trend by age group were implemented with
the log rank test. Three patients, two with haematuria
and one with dysphagia, were excluded from time to
event analyses because of missing ages. A few patients
with cancer diagnoses, up to three cases per site and
sex, that were included previously
15 were excluded
from these analyses because cancer diagnoses were at
the same time or before presentation with the first
symptom.
RESULTS
The study population consisted of 762325 eligible
patients aged 15 and older registered with 128 prac-
tices in 1994. We examined diagnoses made after the
first occurrenceof alarmsymptomsin patientswith no
previous diagnosis of our specified conditions. We
identified 11108 first occurrences of haematuria,
4812 of haemoptysis, 5999 of dysphagia, and 15289
of rectal bleeding between 1 January 1995 and 31
December2000.Fulldetailsoftheageandsexstandar-
dised rates for alarm symptoms and their age specific
incidence rates are available elsewhere.
15 The mean
ageatfirstsymptomwas58.5(SD18.9)forhaematuria,
61.6 (18.0) for dysphagia, 54.5 (19.4) for haemoptysis,
and 52.5 (18.8) for rectal bleeding. The figure shows
the proportion of patients free of any of the selected
outcomes by time since their first alarm symptom.
Patients ceased to be at risk if they were diagnosed
with one or more of the outcomes, died, left the prac-
tice, or reached the end of the study. Although a high
proportion of cases were censored by three years, this
hadlimitedimpactonestimatesasdiagnosesofinterest
were most commonly recorded soon after symptom
onset.
We have presented our main findings for men and
women separately because healthcare use by men and
women is often different and also because some of the
outcomes are sex specific. In patients presenting with
macroscopic haematuria, 17.5% of women and 18.3%
of men had one of the pre-specified diagnoses at
90 days (table 1). At three years these figures rose to
42.0% and 36.6%, respectively, with cystitis and urin-
ary tract infection being the commonest diagnosis in
men and women at three years, followed by urinary
tractcancers(8.0%inmen)andbenignprostatichyper-
trophy (7.3%) in men and menstrual disorders (8.5%)
in women. Urinary tract cancers were less common in
womenatthreeyears(3.7%),withafurther0.4%being
diagnosed with uterine cancer. Orchitis was reported
in 2.6% of men. Renal calculi were reported in 3.8% of
men and 1.5% of women. Although the event rates
were similar across the three age ranges studied in
women, there was a clear age gradient in men, with
significantly higher event rates in men over the age of
64 (χ
2 test for trend: P=0.022 for women, P<0.001 for
men).
Acutelowerrespiratoryinfectionwasthemostcom-
mon diagnosis in men with haemoptysis (10.2% at
90 days and 30.3% at three years). In womenwith hae-
moptysis the most common diagnosiswas acute upper
respiratory infection (10.6% and 47.4%, respectively)
(table 2). At 90 days the prevalence of a diagnosis of
chronic obstructive pulmonary disease (COPD) was
2.7% in women and 2.5% in men, with corresponding
rates for asthma of 4.5% and 2.5%. Severe acute disor-
ders were relatively rare at 90 days, with pulmonary
embolism being diagnosed in only 0.6% of women
and 0.9% of men. Tuberculosis was also rare, with
rates of only 0.3% in women and 0.5% in men at
three years. Cardiac causes of haemoptysis, including
pulmonaryoedemaandmitralstenosis,werealsorare,
evenatthreeyears.Theeventrateswereclearlyrelated
to age at 90 days in both men and women, and in men
at three years, although event rates were fairly evenly
distributed across age groups in women at this time (χ
2
test for trend: P=0.103 for women, P<0.001 for men)
In the patients with dysphagia, 22.6% of men and
17.2% of women had received a definite diagnosis at
90 days (table 3). The commonest diagnosis in both
men and women was oesophagitis (7.1% and 5.4%,
respectively), followed by hiatus hernia (4.6% and
4.8%), followed by disorders of the stomach and duo-
denum. Oesophageal stricture was diagnosed in only
2.9% of men and 1.7% of women. At three years the
rate of important diagnoses had risen to 39.4% in men
and 33.6% in women, with similar rank ordering,
although disorders of the stomach were diagnosed in
11.4% of men and 11.9% of women. The diagnosis of
oesophageal stricture was still relatively rare (4.5% in
Years
Rectal bleeding
0123
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5998 3596 2745 2010
4812 2336 1627 1215
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recorded in this group of patients. A small proportion
of patients were diagnosed with globus hystericus,
pharyngeal pouch, scleroderma, and myasthenia
gravis. Most important diagnoses were more com-
monly identified in older men and women (χ
2 test for
trend: P<0.001 for men and women)
Finally, in patients with rectal bleeding 16.7% of men
and 14.5% of women had received a diagnosis at
90 days, and at three years 32.3% of men and 32.4% of
women had a clear diagnosis (table 4). The most com-
mon diagnosis made at both times was haemorrhoids
(10.0% in men and 7.8% in women at 90 days and
19.0%and16.8%atthreeyears),followedbyanalfissure
anddiverticulitis.NewdiagnosesofCrohn’sdiseaseand
ulcerativecolitis weremadeinless than1%ofwomenat
90 days, with these figures rising to around 1% for
Crohn’s disease and 2% for ulcerative colitis in both
men and women at three years. Small numbers of
patients were found to have bleeding disorders, angio-
dysplasia, intussusception, and Meckel’s diverticulum.
Taking these results together, the “number needed
to evaluate”—that is, the number of patients in whom
clinicallyrelevantdiagnoseswould bemadeasa result
ofinvestigation,calculatedasthereciprocaloftheposi-
tive predictive value—is between four and seven for
the four alarm symptoms studied.
Table 5 shows the incidence of non-cancer diag-
nosesinpatientswhowerelaterdiagnosedwithcancer.
Interval diagnoses were most common for
haemoptysis and included respiratory tract infections
and chronic obstructive pulmonary disease. For the
other alarm symptoms, common interval diagnoses
includedurinarytractinfection,oesophagitisandoeso-
phageal stricture, haemorrhoids, and diverticulitis.
DISCUSSION
Weinvestigatedtheincidenceratesofnon-cancerdiag-
noses in primary care in patients who presented with
four important alarm symptoms. Within 90 days of
presentation, an associated diagnosis had been made
in around 15.3% with rectal bleeding, 19.3% with dys-
phagia, 17.8% with haematuria, and 24.4% with hae-
moptysis. Most of these diagnoses could have been
made clinically or confirmed by performing simple
investigations such as urine culture, chest radiology,
and upper or lower gastrointestinal endoscopy. Over
the three year follow-up these figures rose to about
28.9%, 33.0%, 35.5%, and 53.9%, respectively. The
diagnostic rates for most of the outcomes that were
not sex specific were similar in men and women.
After three years’ follow up, over three quarters of
patients presenting with rectal bleeding did not have
a definite diagnosis, with comparable figures of about
67% for dysphagia, 64% for haematuria, and 46% for
haemoptysis.
Strengths and limitations
The strengths of this study include the large represen-
tative population of patients studied, the accuracy of
Table 1 |Diagnoses 90 days and three years after presentation with haematuria in general practice. Percentages represent positive predictive value
Diagnosis
90 days Three years
Women (n=4723) Men (n=6385) Women (n=4723) Men (n=6385)
No of
patients % (95% CI)
No of
patients % (95% CI)
No of
patients % (95% CI)
No of
patients % (95% CI)
Urinary tract cancer 77 1.7 (1.3 to 2.1) 235 3.8 (3.3 to 4.3) 161 3.7 (3.2 to 4.3) 469 8.0 (7.3 to 8.7)
Renal calculi 28 0.6 (0.4 to 0.9) 121 1.9 (1.6 to 2.3) 64 1.5 (1.2 to 1.9) 227 3.8 (3.4 to 4.4)
Urinary tract infection 670 14.3 (13.3 to 15.3) 587 9.3 (8.6 to 10.0) 1475 34.7 (33.2 to 36.2) 1178 20.6 (19.5 to 21.7)
Benign prostatic
hypertrophy
—— 158 2.5 (2.2 to 2.9) —— 409 7.3 (6.7 to 8.1)
Orchitis —— 51 0.8 (0.6 to 1.1) —— 140 2.6 (2.2 to 3.0)
Menstrual disorders 76 1.6 (1.3 to 2.0) —— 342 8.5 (7.7 to 9.5) ——
Glomerulonephritis 1 0.0 (0.0 to 0.2) 8 0.1 (0.1 to 0.3) 6 0.1 (0.1 to 0.3) 14 0.2 (0.1 to 0.4)
Urethritis 2 0.0 (0.0 to 0.2) 10 0.2 (0.1 to 0.3) 6 0.1 (0.1 to 0.3) 21 0.4 (0.2 to 0.6)
Bleeding disorders 3 0.1 (0.0 to 0.2) 9 0.1 (0.1 to 0.3) 12 0.3 (0.2 to 0.5) 23 0.5 (0.3 to 0.7)
Renal tuberculosis 0 0.0 (0.0 to 0.0) 0 0.0 (0.0 to 0.0) 0 0.0 (0.0 to 0.0) 0 0.0 (0.0 to 0.0)
Polycystic kidneys 1 0.0 (0.0 to 0.2) 5 0.1 (0.0 to 0.2) 3 0.1 (0.0 to 0.2) 5 0.1 (0.0 to 0.2)
Infective endocarditis 0 0.0 (0.0 to 0.0) 2 0.0 (0.0 to 0.1) 2 0.1 (0.0 to 0.2) 2 0.0 (0.0 to 0.1)
Schistosomiasis 0 0.0 (0.0 to 0.0) 0 0.0 (0.0 to 0.0) 0 0.0 (0.0 to 0.0) 0 0.0 (0.0 to 0.0)
Prostate cancer —— 73 1.2 (0.9 to 1.5) —— 178 3.1 (2.7 to 3.6)
Uterine cancer 4 0.1 (0.0 to 0.2) —— 19 0.4 (0.3 to 0.7) ——
Any diagnosis* by age (years):
<45 237 17.5 (15.6 to 19.6) 153 11.8 (10.1 to 13.6) 568 46.1 (43.3 to 49.0) 233 19.1 (17.0 to 21.4)
45-64 187 12.3 (10.7 to 14.0) 313 15.8 (14.3 to 17.5) 473 34.3 (31.8 to 37.0) 577 31.5 (29.4 to 33.7)
>64 395 21.8 (20.0 to 23.8) 690 22.7 (21.3 to 24.2) 759 45.4 (42.9 to 47.8) 1329 47.3 (45.4 to 49.3)
All ages 819 17.5 (16.4 to 18.6) 1156 18.3 (17.4 to 19.3) 1800 42.0 (40.5 to 43.5) 2139 36.6 (35.3 to 37.8)
*Some patients received more than one diagnosis.
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identify enough patients to draw valid conclusions
about the incidence of diagnoses afterthe presentation
ofalarmsymptoms.Severalstudieshaveevaluatedthe
validity of diagnoses recorded in the general practice
research database with generally satisfactory
results.
19-21 All symptoms we evaluated are well
defined and are characterised by only a small number
of Read and Oxmis codes, with little scope for varying
definitions. We have noted previously that our results
show some sensitivity to the scope of case definitions.
Thus the predictive value of dysphagia for cancer
depends on whether stomach cancers as well as oeso-
phageal cancers are included; the predictive value of
haematuria for urinary tract neoplasms depends on
whether prostate cancer is included. Limitations, how-
ever, include the lack of clinical contextual detail con-
cerning the individual alarm symptoms and, in
particular, the fact that we do not know about the
other symptoms that patients might have been experi-
encing when the alarm symptom was recorded in the
general practice record. We rely, of course, on symp-
tom recording rather than symptom reporting and
these might differ. This might be particularly relevant,
forexample,fordysphagia,whichmightrepresentsev-
eral problems such as pain on swallowing or difficulty
in swallowing. We had to rely on the accuracy of
recorded diagnoses and did not have sufficient infor-
mationtoknowwhetherthesediagnosesweremadeon
thebasisofinvestigationsornot.Itmightalsobeworth
considering whether analysis of a more recent dataset,
collectedaftertheintroductionoftheQualityandOut-
comes Framework (QOF), might have changed our
results. We think this is unlikely because the frame-
work will tend to encourage more accurate documen-
tation of chronic disease management rather than
acute disease presentation, and there are no targets
directly related to our alarm symptoms. Although the
90 day follow-up is likely to reflect diagnostic out-
comesofsingleepisodesofthepresentationandinves-
tigation of alarm symptoms, we do not have
information about clinical events and relevant inter-
ventions taking place during the three year follow-up
and,whileweaccountedforpatientsfromanalysiswho
have died and left the practice, we do not have infor-
mation on the extent or severity of disease or its treat-
ment during this time. We concede, of course, that
three year follow-up is not relevant to the natural
course of acute infectious conditions.
Comparison with other studies
Our analyses were implemented in a time to event fra-
mework, allowing for deaths and censoring before three
years. Compared with our earlier paper,
15 predictive
values were estimated to be slightly higher by this
method, with the largest difference being 0.6% at three
yearsforurinarytractcancerafterhaematuriainmen.In
general,censoringhadlimitedimpactontheestimatesof
Table 2 |Diagnoses 90 days and three years after presentation with haemoptysis in general practice. Percentages represent positive predictive value
90 days Three years
Women (n=1882) Men (n=2930) Women (n=1882) Men (n=2930)
No of
patients % (95% CI)
No of
patients % (95% CI)
No of
patients % (95% CI)
No of
patients % (95% CI)
Lung cancer 52 2.8 (2.1 to 3.7) 140 4.9 (4.1 to 5.7) 80 4.5 (3.7 to 5.6) 217 8.0 (7.0 to 9.1)
Acute upper RTI 197 10.6 (9.3 to 12.1) 218 7.5 (6.6 to 8.6) 786 47.4 (44.9 to 49.9) 879 35.0 (33.1 to 37.0)
Acute lower RTI 188 10.1 (8.8 to 11.5) 297 10.2 (9.2 to 11.4) 626 38.0 (35.6 to 40.5) 775 30.3 (28.5 to 32.1)
Chronic obstructive
pulmonary disease
51 2.7 (2.1 to 3.6) 71 2.5 (2.0 to 3.1) 166 10.3 (8.9 to 11.9) 219 8.8 (7.7 to 10.0)
Asthma 84 4.5 (3.7 to 5.6) 72 2.5 (2.0 to 3.1) 254 15.2 (13.5 to 17.1) 242 9.6 (8.5 to 10.9)
Pulmonary embolism 12 0.6 (0.4 to 1.1) 27 0.9 (0.6 to 1.4) 20 1.2 (0.8 to 1.8) 32 1.1 (0.8 to 1.6)
Bleeding disorders 0 0.0 (0.0 to 0.0) 2 0.1 (0.0 to 0.3) 4 0.3 (0.1 to 0.7) 10 0.4 (0.2 to 0.8)
Pulmonary oedema 3 0.2 (0.1 to 0.5) 5 0.2 (0.1 to 0.4) 3 0.2 (0.1 to 0.5) 7 0.2 (0.1 to 0.5)
Mitral stenosis 1 0.1 (0.0 to 0.4) 0 0.0 (0.0 to 0.0) 3 0.2 (0.1 to 0.5) 3 0.1 (0.0 to 0.4)
Polyarteris nodosa 0 0.0 (0.0 to 0.0) 0 0.0 (0.0 to 0.0) 0 0.0 (0.0 to 0.0) 0 0.0 (0.0 to 0.0)
Tuberculosis 4 0.2 (0.1 to 0.6) 7 0.2 (0.1 to 0.5) 6 0.3 (0.2 to 0.7) 12 0.5 (0.3 to 0.8)
Aspergillosis 0 0.0 (0.0 to 0.0) 1 0.0 (0.0 to 0.3) 0 0.0 (0.0 to 0.0) 2 0.1 (0.0 to 0.3)
Goodpasture’s syndrome 0 0.0 (0.0 to 0.0) 0 0.0 (0.0 to 0.0) 0 0.0 (0.0 to 0.0) 0 0.0 (0.0 to 0.0)
Pulmonary arterio-venous
malformation
0 0.0 (0.0 to 0.0) 0 0.0 (0.0 to 0.0) 0 0.0 (0.0 to 0.0) 0 0.0 (0.0 to 0.0)
Bronchiectasis 18 1.0 (0.6 to 1.5) 28 1.0 (0.7 to 1.4) 41 2.4 (1.7 to 3.2) 44 1.6 (1.2 to 2.2)
Any diagnosis* by age (years):
<45 124 22.6 (19.3 to 26.3) 144 15.2 (13.1 to 17.7) 313 60.6 (56.3 to 64.9) 392 45.3 (42.0 to 48.8)
45-64 160 25.4 (22.2 to 29.0) 212 22.9 (20.3 to 25.7) 379 64.0 (60.0 to 68.0) 474 56.3 (52.8 to 59.8)
>64 196 28.5 (25.2 to 32.0) 340 33.0 (30.3 to 36.0) 402 62.1 (58.3 to 66.0) 636 66.2 (63.0 to 69.3)
All ages 480 25.7 (23.8 to 27.8) 696 24.0 (22.5 to 25.6) 1094 62.3 (60.0 to 64.7) 1502 56.2 (54.2 to 58.1)
*Some patients received more than one diagnosis.
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noses was highest soon after the onset of symptoms.
Our figures for diagnostic rates in patients with
haematuria are similar to those reported by Bruy-
ninckx and colleagues in a study from Belgium
22
but are slightly lower than those reported by Sum-
merton and colleagues,
23 who analysed patients
referred to an open access haematuria clinic. In that
studythepopulationwas“enriched”becauseurinary
tract infections had previously been treated or
excluded. Both haematuria and haemoptysis were
strong indicators of the presence or subsequent
development of acute infection, with high rates of
diagnosis of urinary tract infection and cystitis in
both men and women with haematuria and of acute
and chronic respiratory infection in men and women
with haemoptysis. Given the rates of diagnosis of
urinary tract cancer and lung cancer, both at 8% for
men at three years, it is clear that it is important to
pursue an infective or neoplastic cause in patients
presenting in primary care with these symptoms.
The incidence of tuberculosis (<0.5% at three years)
was low in this population, as were diagnoses of
potential cardiac causes of haemoptysis. The diag-
nostic rates in our patients with haemoptysis are
much lower than those commonly emerging from
studies in secondary care,
2425 but no primary care
basedstudiesofthecausesofhaemoptysisinthegen-
eral population have been published.
The predictive value of dysphagia for a serious
organic lesion in the oesophagus has recently been
called into question, not least because dysphagia is
a common symptom in gastro-oesophageal reflux
disease. A recent systematic review of 83 studies
identified wide variation in the sensitivity and speci-
ficity of several alarm symptoms for upper gastro-
intestinal malignancies,
26 and the recently
published Montreal consensus guidelines on gastro-
oesophageal reflux disease
27 have suggested that
only progressive dysphagia should be regarded as
an alarm symptom, pointing out that dysphagia
o f t e ni m p r o v e sw i t ha n t i - s e c r e t o r yt r e a t m e n ti n
many reflux patients. Our data, however, do not
entirely support this view. The diagnostic rates for
cancer and oesophageal stricture at 90 days were
4.4% and 2.9%, respectively, in men and 1.8% and
1.7% in women, and at three years were 5.9% and
4.5%, respectively, in men and 2.5% and 2.7% in
women. The highest detection rates were found in
older men and women. Corresponding figures for a
diagnosis of oesophagitis in men were 7.1% at
90daysand14.7%atthreeyears,suggestingthatdys-
phagia should be taken seriously as a warning of an
organic oesophageal lesion, particularly in older
patients. The importance of hiatus hernia as a diag-
nosis is uncertain. At three years, between one in
threeandoneinfivepatientspresentingwithdyspha-
gia received a diagnosis of gastrointestinal disorders,
including gastritis, gastric ulcer, and duodenal ulcer,
addingfurtherweighttotheimportanceofdysphagia
asawarningsignforimportantuppergastrointestinal
pathology.
Given the current focus on screening for colorectal
cancer, the importance of rectal bleeding is of
Table 3 |Diagnoses 90 days and three years after presentation with dysphagia in general practice. Percentages represent positive predictive value
90 days Three years
Women (n=3371) Men (n=2628) Women (n=3371) Men (n=2628)
No of
patients % (95% CI)
No of
patients % (95% CI)
No of
patients % (95% CI)
No of
patients % (95% CI)
Oesophageal cancer 59 1.8 (1.4 to 2.3) 114 4.4 (3.7 to 5.3) 80 2.5 (2.0 to 3.1) 149 5.9 (5.0 to 6.9)
Oesophagitis 180 5.4 (4.7 to 6.2) 184 7.1 (6.2 to 8.2) 354 11.8 (10.7 to 13.1) 348 14.7 (13.3 to 16.2)
Oesophageal stricture 56 1.7 (1.3 to 2.2) 76 2.9 (2.4 to 3.7) 85 2.7 (2.2 to 3.4) 110 4.5 (3.7 to 5.4)
Hiatus hernia 159 4.8 (4.1 to 5.6) 119 4.6 (3.9 to 5.5) 277 9.1 (8.1 to 10.2) 203 8.5 (7.5 to 9.7)
Gastritis 57 1.7 (1.3 to 2.2) 64 2.5 (1.9 to 3.2) 133 4.5 (3.8 to 5.4) 131 5.6 (4.8 to 6.7)
Stomach disorders 90 2.7 (2.2 to 3.3) 86 3.3 (2.7 to 4.1) 333 11.9 (10.8 to 13.2) 252 11.4 (10.1 to 12.8)
Peptic ulcer 39 1.2 (0.9 to 1.6) 63 2.4 (1.9 to 3.1) 72 2.4 (1.9 to 3.1) 112 4.8 (4.0 to 5.7)
Globus hystericus 12 0.4 (0.2 to 0.6) 6 0.2 (0.1 to 0.5) 32 1.1 (0.8 to 1.6) 9 0.4 (0.2 to 0.7)
Pharyngeal pouch 10 0.3 (0.2 to 0.6) 13 0.5 (0.3 to 0.9) 16 0.5 (0.3 to 0.8) 22 0.9 (0.6 to 1.4)
Chagas’ disease 0 0.0 (0.0 to 0.0) 0 0.0 (0.0 to 0.0) 0 0.0 (0.0 to 0.0) 0 0.0 (0.0 to 0.0)
Scleroderma 2 0.1 (0.0 to 0.2) 0 0.0 (0.0 to 0.0) 11 0.4 (0.2 to 0.7) 1 0.0 (0.0 to 0.3)
Myasthenia gravis 2 0.1 (0.0 to 0.2) 0 0.0 (0.0 to 0.0) 2 0.1 (0.0 to 0.2) 0 0.0 (0.0 to 0.0)
Gastric cancer 16 0.5 (0.3 to 0.8) 23 0.9 (0.6 to 1.3) 25 0.8 (0.5 to 1.2) 36 1.5 (1.1 to 2.1)
Achalasia 0 0.0 (0.0 to 0.0) 0 0.0 (0.0 to 0.0) 0 0.0 (0.0 to 0.0) 0 0.0 (0.0 to 0.0)
Any diagnosis* by age (years):
<45 45 7.1 (5.4 to 9.4) 47 9.9 (7.5 to 12.9) 110 20.2 (17.0 to 24.0) 106 24.7 (20.8 to 29.2)
45-64 167 16.3 (14.1 to 18.7) 239 25.7 (23.1 to 28.7) 321 34.2 (31.2 to 37.5) 389 44.9 (41.5 to 48.4)
>64 360 21.6 (19.7 to 23.6) 301 25.2 (22.8 to 27.8) 594 38.2 (35.8 to 40.8) 458 41.1 (38.1 to 44.1)
All ages 572 17.2 (16.0 to 18.5) 587 22.6 (21.0 to 24.3) 1,025 33.6 (31.9 to 35.3) 953 39.4 (37.4 to 41.5)
*Some patients received more than one diagnosis.
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value of rectal bleeding for a cancer diagnosis at
90 days was a little over 1%, rising to between 2% and
3%inmenandwomenatthreeyears,withhigherrates
in older age groups. These figures are broadly consis-
tent with another study from the general practice
research database
28 and also with a prospective study
conducted in primary care in southern England. Diag-
nosis rates after presentation with rectal bleeding were
thelowestofthe fouralarmsymptomsthatwestudied,
and most patients turned out to have haemorrhoids or
an anal fissure. Rates of diagnosis of inflammatory
bowel disease (Crohn’s disease and ulcerative colitis)
were surprisingly low in this population, with diagnos-
tic rates for both of less than 1% at 90 days and around
1% for Crohn’s disease and 2% for ulcerative colitis at
three years. The diagnosis of a bleeding disorder was
extremely rare in all four conditions, but occurred
most often in patients with rectal bleeding. While we
recognise that rectal bleeding is an alarm symptom,
likely to trigger concern about a serious diagnosis, it
is clearly important to consider the patternof bleeding
and accompanying symptoms, which, as Robertson
and colleagues point out,
29 might considerably
increase the likelihood of cancer.
The interpretation of our findings will depend, to a
large extent, on the clinical context in which the alarm
symptom is presented and, in particular, on the pre-
sence of other symptoms or signs that may or may
not add to the diagnostic probability of a serious
organic problem. Patients with haemoptysis who are
febrile and coughing up infected sputum are, clearly,
more likely to have an infective cause for their symp-
toms than someone with haemoptysis experienced in
thecontextofacuteonsetofpleuriticchestpain.When
accompanied by dysuria and urinary frequency, hae-
maturia is clearly more likely to be related to a urinary
tract infection than the same symptom occurring with-
out pain and without disturbance of bladder function.
Dysphagia in the absence of symptoms suggestive of
gastro-oesophageal reflux disease, particularly when
progressive, should clearly be taken seriously, and
our data suggest that dysphagia is an important alarm
symptom for the diagnosis of cancer or oesophageal
stricture. Rectal bleeding remains problematic, and it
is a difficult matter of clinical judgment as to whether
Table 5 |Proportion of patients diagnosed with cancer who also had non-cancer diagnosis recorded after onset of symptoms and before diagnosis of cancer
Haematuria:
urinary tract cancer
Haemoptysis:
lung cancer
Dysphagia:
oesophageal cancer
Rectal bleeding:
colorectal cancer
No with diagnosis of cancer 630 297 229 332
No (%) with preceding non-cancer
diagnosis
135 (21) 155 (52) 71 (31) 49 (15)
Most common diagnoses Urinary tract infection
(112)
Upper respiratory tract infection (35); lower respiratory
tract infection (71); chronic obstructive pulmonary
disease (25); asthma (18)
Oesophageal stricture (29);
oesophagitis (18)
Haemorrhoids (21);
diverticulitis (13)
Table 4 |Diagnoses 90 days and three years after presentation with rectal bleeding in general practice. Percentages represent positive predictive value
90 days Three years
Women (n=7766) Men (n=7523) Women (n=7766) Men (n=7523)
No of
patients % (95% CI)
No of
patients % (95% CI)
No of
patients % (95% CI)
No of
patients % (95% CI)
Colorectal cancer 78 1.0 (0.8 to 1.3) 98 1.3 (1.1 to 1.6) 151 2.1 (1.8 to 2.5) 181 2.7 (2.3 to 3.1)
Peptic ulcer 25 0.3 (0.2 to 0.5) 38 0.5 (0.4 to 0.7) 79 1.3 (1.0 to 1.6) 110 1.8 (1.5 to 2.2)
Diverticulitis 231 3.0 (2.7 to 3.4) 195 2.6 (2.3 to 3.0) 497 7.1 (6.5 to 7.7) 375 5.6 (5.0 to 6.1)
Anal fissure 92 1.2 (1.0 to 1.5) 95 1.3 (1.1 to 1.6) 226 3.4 (3.0 to 3.9) 187 2.8 (2.5 to 3.3)
Crohn’s disease 38 0.5 (0.4 to 0.7) 19 0.3 (0.2 to 0.4) 68 1.0 (0.8 to 1.2) 47 0.8 (0.6 to 1.0)
Ulcerative colitis 60 0.8 (0.6 to 1.0) 64 0.9 (0.7 to 1.1) 129 1.9 (1.6 to 2.3) 146 2.2 (1.9 to 2.6)
Infective colitis 47 0.6 (0.5 to 0.8) 38 0.5 (0.4 to 0.7) 257 4.2 (3.7 to 4.8) 178 3.1 (2.6 to 3.5)
Haemorrhoids 596 7.8 (7.2 to 8.4) 738 10.0 (9.3 to 10.7) 1143 16.8 (15.9 to 17.7) 1282 19.0 (18.0 to 19.9)
Bleeding disorders 4 0.1 (0.0 to 0.1) 7 0.1 (0.1 to 0.2) 26 0.4 (0.3 to 0.6) 14 0.2 (0.1 to 0.4)
Angiodysplasia 0 0.0 (0.0 to 0.0) 2 0.0 (0.0 to 0.1) 1 0.0 (0.0 to 0.1) 6 0.1 (0.0 to 0.2)
Intussusception 1 0.0 (0.0 to 0.1) 0 0.0 (0.0 to 0.0) 1 0.0 (0.0 to 0.1) 0 0.0 (0.0 to 0.0)
Meckel’s diverticulum 0 0.0 (0.0 to 0.0) 0 0.0 (0.0 to 0.0) 0 0.0 (0.0 to 0.0) 1 0.0 (0.0 to 0.1)
Any diagnosis* by age (years):
<45 282 10.3 (9.2 to 11.5) 323 12.1 (11.0 to 13.4) 672 28.0 (26.1 to 29.9) 646 26.9 (25.1 to 28.8)
45-64 364 14.9 (13.6 to 16.4) 513 18.3 (16.9 to 19.8) 715 32.8 (30.8 to 34.9) 894 34.7 (32.9 to 36.7)
>64 461 18.6 (17.2 to 20.2) 400 20.5 (18.8 to 22.3) 840 36.8 (34.8 to 38.9) 654 36.3 (34.1 to 38.7)
All ages 1107 14.5 (13.7 to 15.3) 1236 16.7 (15.8 to 17.5) 2227 32.4 (31.2 to 33.5) 2194 32.3 (31.2 to 33.5)
*Some patients received more than one diagnosis.
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years indicate investigation. Because of the frequent
co-existence of perianal and more serious large bowel
lesions, the presence of perianal pain or local bleeding
should not be taken to exclude colon cancer, and it is
probable that persistent, otherwise unexplained rectal
bleeding merits urgent investigation. It is not clear
from our data whether rectal bleeding is a valuable
alarm symptom for the presence of inflammatory
boweldisease,whichismorelikelytopresentasbleed-
ing in combination with altered bowel habit, diar-
rhoea, abdominal pain, and other related symptoms.
Even in our analysis of outcomes in single alarm
symptoms, without additional information on coexist-
ingsymptomsandsigns,uptooneinfivepatientshada
diagnosisat90days,andthisproportionwouldalmost
certainly have been higher in patients with multiple
symptoms as described above. We argue that in
patientswiththese,andperhapsother,“redflag”symp-
toms, particularly when accompanied by other fea-
tures supportive of specific important diagnoses, the
use of the “test of time” might be inappropriate and
that early investigation should be recommended.
Conclusions
Webelievethatthesedataprovideadditionalinforma-
tion to help clinicians manage patients presenting with
symptoms suggestive of serious disease. In general
terms they support the notion of alarm symptoms,
which, because they possess reasonable predictive
valueforseriousdisease,shouldstimulateurgentinter-
vention, notwithstanding the fact that the diagnoses
made most often tend to be the least serious. We
have, in conducting the study, extended the concept
of “alarmsymptoms” to includeimportant non-cancer
diagnoses, emphasising that these symptoms are not
only red flags for malignancy but also “yellow flags”
thatshouldpromptclinicianstoconductinvestigations
or intervene therapeutically in thesebenign but poten-
tially serious disorders. For many of these patients the
test of time should probably be replaced by a “timely
test,” although the interpretation of our data, in terms
of the need for exhaustive investigation, is likely to
vary according to the resources available in different
healthcare systems. Further research in the primary
care setting, using both large databases and prospec-
tive clinical cohorts, is required to better define symp-
tom combinations and other clinical features that
represent the most important targets for investigation
and treatment to optimise the use of scarce resources
and to minimise overinvestigation and unnecessary
treatment. Because some of the conditions, such as
respiratory and urinary tract infections and haemor-
rhoids, are common in the general population, further
researchisrequiredtoevaluatetheoccurrenceofthese
diagnoses in controls with alarm symptoms. This
research could then be followed by trials to evaluate
the costs and outcomes of different strategies for the
investigation of patients with alarm symptoms.
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